Discontinued — last reported Q1 '18
Veeva Systems Allowance for Doubtful Accounts Receivable (Current) decreased by 71.6% to $171.00K in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.9%, from $157.00K to $171.00K. Over 4 years (FY 2021 to FY 2025), Allowance for Doubtful Accounts Receivable (Current) shows a downward trend with a -26.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_current| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $358.00K | $335.00K | $396.00K | $473.00K | $448.00K | $510.00K | $1.44M | $469.00K | $542.00K | $551.00K | $554.00K | $520.00K | $216.00K | $249.00K | $157.00K | $57.00K | $563.00K | $602.00K | $171.00K |
| QoQ Change | — | -6.4% | +18.2% | +19.4% | -5.3% | +13.8% | +182.7% | -67.5% | +15.6% | +1.7% | +0.5% | -6.1% | -58.5% | +15.3% | -36.9% | -63.7% | +887.7% | +6.9% | -71.6% |
| YoY Change | — | — | — | — | +25.1% | +52.2% | +264.1% | -0.8% | +21.0% | +8.0% | -61.6% | +10.9% | -60.1% | -54.8% | -71.7% | -89.0% | +160.6% | +141.8% | +8.9% |